- Home
- TLSI vs CSPI Comparison
TLSI vs CSPI Comparison
Compare TLSI & CSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- CSPI
- Stock Information
- Founded
- TLSI 2010
- CSPI 1968
- Country
- TLSI United States
- CSPI United States
- Employees
- TLSI N/A
- CSPI N/A
- Industry
- TLSI Medical Specialities
- CSPI EDP Services
- Sector
- TLSI Health Care
- CSPI Technology
- Exchange
- TLSI Nasdaq
- CSPI Nasdaq
- Market Cap
- TLSI 160.4M
- CSPI 146.9M
- IPO Year
- TLSI N/A
- CSPI 1987
- Fundamental
- Price
- TLSI $5.02
- CSPI $16.43
- Analyst Decision
- TLSI Strong Buy
- CSPI
- Analyst Count
- TLSI 6
- CSPI 0
- Target Price
- TLSI $11.75
- CSPI N/A
- AVG Volume (30 Days)
- TLSI 34.6K
- CSPI 13.7K
- Earning Date
- TLSI 05-23-2025
- CSPI 05-20-2025
- Dividend Yield
- TLSI N/A
- CSPI 0.73%
- EPS Growth
- TLSI N/A
- CSPI N/A
- EPS
- TLSI N/A
- CSPI 0.02
- Revenue
- TLSI $29,431,000.00
- CSPI $55,514,000.00
- Revenue This Year
- TLSI $55.13
- CSPI N/A
- Revenue Next Year
- TLSI $50.71
- CSPI N/A
- P/E Ratio
- TLSI N/A
- CSPI $877.49
- Revenue Growth
- TLSI 58.99
- CSPI N/A
- 52 Week Low
- TLSI $3.50
- CSPI $10.76
- 52 Week High
- TLSI $10.24
- CSPI $21.95
- Technical
- Relative Strength Index (RSI)
- TLSI 34.87
- CSPI 53.07
- Support Level
- TLSI $4.66
- CSPI $15.56
- Resistance Level
- TLSI $5.40
- CSPI $17.19
- Average True Range (ATR)
- TLSI 0.37
- CSPI 0.82
- MACD
- TLSI -0.06
- CSPI 0.03
- Stochastic Oscillator
- TLSI 29.51
- CSPI 60.42
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About CSPI CSP Inc.
CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.